Pharmaceutical Executive, November 2017 Issue (PDF)

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-11-01-2017
Volume 37
Issue 11

Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.

External Link - PharmExec_ Regular Issue _Nov2017.pdf

Articles in this issue
Pharm Exec's 2018 Pipeline Report
Pharm Exec's 2018 Pipeline Report
Taiwan’s Biotech Boom
Taiwan’s Biotech Boom
The Fine Line of Pharma & Patient Group Collaboration
The Fine Line of Pharma & Patient Group Collaboration
Wash sidebar.png
FDA Explores Flexible Drug Marketing Policies
Lisa Henderson thumbnail.jpg
No Overnight Successes
Early Engage PQ.png
Aligning Early Advice with Long-Term Planning
NASH table 2.png
Navigating the Untapped NASH Market
Story-2_Neil-Grubert-1-New-1510081515324.jpg
Interpreting UK’s Post-Brexit Life Sciences Strategy
HIPAA checklist.png
When HIPAA Doesn’t Apply
i1.jpg
Country Report: Austria
Pharmaceutical Executive, November 2017 Issue (PDF)
Recent Videos
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Most Effective Strategies to Close the Innovation Gap in Women’s Health
Root Causes of Innovation Gap in Women’s Health
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Related Content
Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

Don Tracy, Associate Editor
March 25th 2025
Article

Under terms of the deal, Merck will gain global rights to develop, manufacture, and commercialize HRS-5346 for cardiovascular disease, excluding Greater China.

Peter Ax, UpScriptHealth

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
March 24th 2025
Podcast

Peter Ax, founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry and how digital health platforms could potentially help offset them.

Stock.adobe.com

USPTO Grants Notice of Allowance to Anixa Bioscience’s Ovarian Cancer Vaccine

Mike Hollan
March 25th 2025
Article

The potential vaccine is being developed in partnership with the Cleveland Clinic and the NCI.

Jennifer Butler

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
March 11th 2025
Podcast

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

Miranda Schmalfuhs
March 25th 2025
Article

The latest news for pharma industry insiders.

The 8 Market Access Performance Metrics You Should Be Tracking

Access Infinity
March 25th 2025
Article

This guide offers an in-depth analysis of the essential KPIs that market access teams should track to measure success particularly across speed of access, breadth of access, and price performance. It includes real-life use cases and practical steps on how to get started.